Pediatrix Medical Group Executive Compensation Details
Ticker: MD · Form: DEF 14A · Filed: Mar 28, 2025 · CIK: 893949
| Field | Detail |
|---|---|
| Company | Pediatrix Medical Group, INC. (MD) |
| Form Type | DEF 14A |
| Filed Date | Mar 28, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-compensation, proxy-statement, equity-awards
TL;DR
Pediatrix exec pay details out, equity awards for 2020-2022 are in focus.
AI Summary
Pediatrix Medical Group, Inc. filed a DEF 14A on March 28, 2025, detailing executive compensation and corporate governance matters. The filing includes information on equity awards granted to its PEO and non-PEO members for fiscal years ending December 31, 2020, 2021, and 2022, with specific data on the year-end fair value of outstanding awards and changes in fair value.
Why It Matters
This filing provides transparency into how Pediatrix Medical Group compensates its top executives, which can influence investor decisions and employee morale.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of executive compensation and corporate governance, not indicating immediate financial risk.
Key Numbers
- 2020-2022 — Fiscal Years (Executive equity awards data covered)
Key Players & Entities
- Pediatrix Medical Group, Inc. (company) — Filer
- MEDNAX, INC. (company) — Former Company Name
- PEDIATRIX MEDICAL GROUP INC (company) — Former Company Name
FAQ
What is the primary purpose of a DEF 14A filing?
A DEF 14A filing, also known as a Definitive Proxy Statement, is used to solicit shareholder votes on important corporate matters, such as the election of directors, executive compensation, and other significant proposals.
What specific compensation elements are detailed for Pediatrix Medical Group's executives in this filing?
The filing details equity awards granted to PEO (Principal Executive Officer) and non-PEO members for fiscal years ending December 31, 2020, 2021, and 2022, including year-end fair value of outstanding awards and changes in fair value.
When was Pediatrix Medical Group, Inc. previously known by other names?
Pediatrix Medical Group, Inc. was formerly known as MEDNAX, INC. (name change effective January 2, 2009) and PEDIATRIX MEDICAL GROUP INC (name change effective August 1, 1995).
What is the filing date and period of report for this DEF 14A?
This DEF 14A filing was made on March 28, 2025, and the period of report is March 26, 2025.
Where is Pediatrix Medical Group, Inc. headquartered?
Pediatrix Medical Group, Inc. is headquartered at 1301 Concord Terrace, Sunrise, FL 33323.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on March 28, 2025 regarding Pediatrix Medical Group, Inc. (MD).